Amdocs Limited
DOX
$87.43
-$1.36-1.53%
| Weiss Ratings | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Reward Grade | B | |||
| Rating Factors | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Fair | |||
| Growth Index | Fair | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.53 | |||
| Price History | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.70% | |||
| 30-Day Total Return | 0.80% | |||
| 60-Day Total Return | 0.91% | |||
| 90-Day Total Return | -0.80% | |||
| Year to Date Total Return | 3.89% | |||
| 1-Year Total Return | -4.14% | |||
| 2-Year Total Return | 1.40% | |||
| 3-Year Total Return | 17.13% | |||
| 5-Year Total Return | 72.76% | |||
| 52-Week High % Change | -5.37% | |||
| 52-Week Low % Change | 19.33% | |||
| Price | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $93.83 | |||
| 52-Week Low Price | $74.41 | |||
| 52-Week Low Price (Date) | Jun 14, 2024 | |||
| 52-Week High Price (Date) | Mar 14, 2024 | |||
| Valuation | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 9.96B | |||
| Enterprise Value | 10.45B | |||
| Price/Earnings (TTM) | 20.58 | |||
| Earnings Per Share (TTM) | 4.31 | |||
| Earnings Per Share Growth | -7.71% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 2.07 | |||
| Price/Book (Q) | 2.87 | |||
| Enterprise Value/Revenue (TTM) | 2.14 | |||
| Price | $87.43 | |||
| Enterprise Value/EBITDA (TTM) | 10.72 | |||
| Enterprise Value/EBIT | 13.37 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 113.44M | |||
| Dividend Yield | 2.16% | |||
| Div. Per Share (Most Recent) | $0.48 | |||
| Dividend Per Share (TTM) | $1.92 | |||
| Payout Ratio (TTM) | 43.31% | |||
| Dividend Per Share (Most Recent) | $0.48 | |||
| Company Info | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 314 212 7000 | |||
| Address | 625 Maryville Centre Drive Saint Louis, MO 63141 | |||
| Website | www.amdocs.com | |||
| Country | United States | |||
| Year Founded | 1982 | |||
| Profitability | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 16.03% | |||
| Profit Margin | 10.19% | |||
| Management Effectiveness | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 7.65% | |||
| Return on Equity | 14.05% | |||
| Income Statement | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 4.87B | |||
| Total Revenue (TTM) | 4.87B | |||
| Revenue Per Share | $42.93 | |||
| Gross Profit (TTM) | 1.75B | |||
| EBITDA (TTM) | 974.60M | |||
| EBIT (TTM) | 780.98M | |||
| Net Income (TTM) | 496.37M | |||
| Net Income Avl. to Common (TTM) | 496.37M | |||
| Total Revenue Growth (Q YOY) | -10.85% | |||
| Earnings Growth (Q YOY) | 2.10% | |||
| EPS Diluted (TTM) | 4.31 | |||
| EPS Diluted Growth (Q YOY) | 5.83% | |||
| Balance Sheet | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 349.01M | |||
| Cash Per Share (Q) | $3.08 | |||
| Total Current Assets (Q) | 1.61B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 3.51B | |||
| Current Ratio (Q) | 1.160 | |||
| Book Value Per Share (Q) | $30.89 | |||
| Total Assets (Q) | 6.29B | |||
| Total Current Liabilities (Q) | 1.38B | |||
| Total Debt (Q) | 793.79M | |||
| Total Liabilities (Q) | 2.79B | |||
| Total Common Equity (Q) | 3.46B | |||
| Cash Flow | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -50.53M | |||
| Cash from Financing (TTM) | -766.12M | |||
| Net Change in Cash (TTM) | -169.05M | |||
| Levered Free Cash Flow (TTM) | 604.43M | |||
| Cash from Operations (TTM) | 647.60M | |||
